Key facts
- It has raised $30.6M across 3 recorded rounds; the latest was Seed Round ($714K) in Apr 2017.
- Notable investors include eGrowth Ventures, Kansas Bioscience Authority, Keith Harrington, Mid America Angels, Women's Capital Connection.
- ELIAS Animal Health has filed 3 Form Ds with the SEC since 2015, most recently May 2017 ($714K sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ELIAS Animal Health
Funding rounds
3 roundsAbout ELIAS Animal Health
Operator of a medical biotechnology company intended to provide cancer treatment for pets. The company helps harness the power of the dog's immune system to eliminate cancer by utilizing adoptive cell therapy to deliver an army of activated T-cells that kill cancer cells, enabling veterinarians and pet owners to have access to a new approach to cancer treatment.
- Sector
- Healthcare
- HQ
- Lenexa, KS, United States
- Founded
- 2014
- Employees
- 8
- Website
- eliasanimalhealth.com/
- Ownership
- Privately Held (backing)
ELIAS Animal Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ELIAS Animal Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ELIAS Animal Health in its N-PORT filings yet. We sweep new filings monthly.